1 Report Overview 1.1 Valeramide Research Scope 1.2 Market Segment by Type 1.2.1 Global Valeramide Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Purity 97% 1.2.3 Purity 98% 1.2.4 Purity 99% 1.3 Market Segment by Application 1.3.1 Global Valeramide Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Chemical Reagents 1.3.3 Pharmaceutical Intermediates 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Market Production 2.1 Global Valeramide Production Capacity (2017-2028) 2.2 Global Valeramide Production by Region: 2017 VS 2021 VS 2028 2.3 Global Valeramide Production by Region 2.3.1 Global Valeramide Historic Production by Region (2017-2022) 2.3.2 Global Valeramide Forecasted Production by Region (2023-2028) 2.3.3 North America 2.3.4 Europe 2.3.5 Japan 2.3.6 China 2.3.7 South Korea 2.3.8 India 2.4 Market Dynamics 2.4.1 Valeramide Industry Trends 2.4.2 Valeramide Market Drivers 2.4.3 Valeramide Market Challenges 2.4.4 Valeramide Market Restraints 3 Global Valeramide Sales 3.1 Global Valeramide Sales Estimates and Forecasts 2017-2028 3.2 Global Valeramide Revenue Estimates and Forecasts 2017-2028 3.3 Global Valeramide Revenue by Region: 2017 VS 2021 VS 2028 3.4 Global Top Valeramide Regions by Sales 3.4.1 Global Top Valeramide Regions by Sales (2017-2022) 3.4.2 Global Top Valeramide Regions by Sales (2023-2028) 3.5 Global Top Valeramide Regions by Revenue 3.5.1 Global Top Valeramide Regions by Revenue (2017-2022) 3.5.2 Global Top Valeramide Regions by Revenue (2023-2028) 3.5.3 North America 3.5.4 Europe 3.5.5 Asia-Pacific 3.5.6 Latin America 3.5.7 Middle East & Africa 4 Competition by Manufacturers 4.1 Global Valeramide Production Capacity by Manufacturers 4.2 Global Valeramide Sales by Manufacturers 4.2.1 Global Top Valeramide Manufacturers by Sales (2017-2022) 4.2.2 Global Top Valeramide Manufacturers Market Share by Sales (2017-2022) 4.2.3 Global Top 10 and Top 5 Companies by Valeramide Sales in 2021 4.3 Global Valeramide Revenue by Manufacturers 4.3.1 Global Top Valeramide Manufacturers by Revenue (2017-2022) 4.3.2 Global Top Valeramide Manufacturers Market Share by Revenue (2017-2022) 4.3.3 Global Top 10 and Top 5 Companies by Valeramide Revenue in 2021 4.4 Global Valeramide Sales Price by Manufacturers 4.5 Analysis of Competitive Landscape 4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 4.5.2 Global Valeramide Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.5.3 Global Valeramide Manufacturers Geographical Distribution 4.6 Mergers & Acquisitions, Expansion Plans 5 Estimates and Forecasts by Type 5.1 Global Valeramide Sales by Type 5.1.1 Global Valeramide Historical Sales by Type (2017-2022) 5.1.2 Global Valeramide Forecasted Sales by Type (2023-2028) 5.1.3 Global Valeramide Sales Market Share by Type (2017-2028) 5.2 Global Valeramide Revenue by Type 5.2.1 Global Valeramide Historical Revenue by Type (2017-2022) 5.2.2 Global Valeramide Forecasted Revenue by Type (2023-2028) 5.2.3 Global Valeramide Revenue Market Share by Type (2017-2028) 5.3 Global Valeramide Price by Type 5.3.1 Global Valeramide Price by Type (2017-2022) 5.3.2 Global Valeramide Price Forecast by Type (2023-2028) 6 Market Size by Application 6.1 Global Valeramide Sales by Application 6.1.1 Global Valeramide Historical Sales by Application (2017-2022) 6.1.2 Global Valeramide Forecasted Sales by Application (2023-2028) 6.1.3 Global Valeramide Sales Market Share by Application (2017-2028) 6.2 Global Valeramide Revenue by Application 6.2.1 Global Valeramide Historical Revenue by Application (2017-2022) 6.2.2 Global Valeramide Forecasted Revenue by Application (2023-2028) 6.2.3 Global Valeramide Revenue Market Share by Application (2017-2028) 6.3 Global Valeramide Price by Application 6.3.1 Global Valeramide Price by Application (2017-2022) 6.3.2 Global Valeramide Price Forecast by Application (2023-2028) 7 North America 7.1 North America Valeramide Sales Breakdown by Company 7.1.1 North America Valeramide Sales by Company (2017-2022) 7.1.2 North America Valeramide Revenue by Company (2017-2022) 7.2 North America Valeramide Market Size by Type 7.2.1 North America Valeramide Sales by Type (2017-2028) 7.2.2 North America Valeramide Revenue by Type (2017-2028) 7.3 North America Valeramide Market Size by Application 7.3.1 North America Valeramide Sales by Application (2017-2028) 7.3.2 North America Valeramide Revenue by Application (2017-2028) 7.4 North America Valeramide Market Size by Country 7.4.1 North America Valeramide Sales by Country (2017-2028) 7.4.2 North America Valeramide Revenue by Country (2017-2028) 7.4.3 U.S. 7.4.4 Canada 8 Europe 8.1 Europe Valeramide Sales Breakdown by Company 8.1.1 Europe Valeramide Sales by Company (2017-2022) 8.1.2 Europe Valeramide Revenue by Company (2017-2022) 8.2 Europe Valeramide Market Size by Type 8.2.1 Europe Valeramide Sales by Type (2017-2028) 8.2.2 Europe Valeramide Revenue by Type (2017-2028) 8.3 Europe Valeramide Market Size by Application 8.3.1 Europe Valeramide Sales by Application (2017-2028) 8.3.2 Europe Valeramide Revenue by Application (2017-2028) 8.4 Europe Valeramide Market Size by Country 8.4.1 Europe Valeramide Sales by Country (2017-2028) 8.4.2 Europe Valeramide Revenue by Country (2017-2028) 8.4.3 Germany 8.4.4 France 8.4.5 U.K. 8.4.6 Italy 8.4.7 Russia 9 Asia Pacific 9.1 Asia Pacific Valeramide Sales Breakdown by Company 9.1.1 Asia Pacific Valeramide Sales by Company (2017-2022) 9.1.2 Asia Pacific Valeramide Revenue by Company (2017-2022) 9.2 Asia Pacific Valeramide Market Size by Type 9.2.1 Asia Pacific Valeramide Sales by Type (2017-2028) 9.2.2 Asia Pacific Valeramide Revenue by Type (2017-2028) 9.3 Asia Pacific Valeramide Market Size by Application 9.3.1 Asia Pacific Valeramide Sales by Application (2017-2028) 9.3.2 Asia Pacific Valeramide Revenue by Application (2017-2028) 9.4 Asia Pacific Valeramide Market Size by Region 9.4.1 Asia Pacific Valeramide Sales by Region (2017-2028) 9.4.2 Asia Pacific Valeramide Revenue by Region (2017-2028) 9.4.3 China 9.4.4 Japan 9.4.5 South Korea 9.4.6 India 9.4.7 Australia 9.4.8 Taiwan 9.4.9 Indonesia 9.4.10 Thailand 9.4.11 Malaysia 9.4.12 Philippines 10 Latin America 10.1 Latin America Valeramide Sales Breakdown by Company 10.1.1 Latin America Valeramide Sales by Company (2017-2022) 10.1.2 Latin America Valeramide Revenue by Company (2017-2022) 10.2 Latin America Valeramide Market Size by Type 10.2.1 Latin America Valeramide Sales by Type (2017-2028) 10.2.2 Latin America Valeramide Revenue by Type (2017-2028) 10.3 Latin America Valeramide Market Size by Application 10.3.1 Latin America Valeramide Sales by Application (2017-2028) 10.3.2 Latin America Valeramide Revenue by Application (2017-2028) 10.4 Latin America Valeramide Market Size by Country 10.4.1 Latin America Valeramide Sales by Country (2017-2028) 10.4.2 Latin America Valeramide Revenue by Country (2017-2028) 10.4.3 Mexico 10.4.4 Brazil 10.4.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Valeramide Sales Breakdown by Company 11.1.1 Middle East and Africa Valeramide Sales by Company (2017-2022) 11.1.2 Middle East and Africa Valeramide Revenue by Company (2017-2022) 11.2 Middle East and Africa Valeramide Market Size by Type 11.2.1 Middle East and Africa Valeramide Sales by Type (2017-2028) 11.2.2 Middle East and Africa Valeramide Revenue by Type (2017-2028) 11.3 Middle East and Africa Valeramide Market Size by Application 11.3.1 Middle East and Africa Valeramide Sales by Application (2017-2028) 11.3.2 Middle East and Africa Valeramide Revenue by Application (2017-2028) 11.4 Middle East and Africa Valeramide Market Size by Country 11.4.1 Middle East and Africa Valeramide Sales by Country (2017-2028) 11.4.2 Middle East and Africa Valeramide Revenue by Country (2017-2028) 11.4.3 Turkey 11.4.4 Saudi Arabia 11.4.5 U.A.E 12 Company Profiles 12.1 TCI 12.1.1 TCI Corporation Information 12.1.2 TCI Overview 12.1.3 TCI Valeramide Sales, Revenue, Price and Gross Margin (2017-2022) 12.1.4 TCI Valeramide Products and Services 12.1.5 TCI Valeramide SWOT Analysis 12.1.6 TCI Recent Developments 12.2 Alfa Chemistry 12.2.1 Alfa Chemistry Corporation Information 12.2.2 Alfa Chemistry Overview 12.2.3 Alfa Chemistry Valeramide Sales, Revenue, Price and Gross Margin (2017-2022) 12.2.4 Alfa Chemistry Valeramide Products and Services 12.2.5 Alfa Chemistry Valeramide SWOT Analysis 12.2.6 Alfa Chemistry Recent Developments 12.3 Acros Organics 12.3.1 Acros Organics Corporation Information 12.3.2 Acros Organics Overview 12.3.3 Acros Organics Valeramide Sales, Revenue, Price and Gross Margin (2017-2022) 12.3.4 Acros Organics Valeramide Products and Services 12.3.5 Acros Organics Valeramide SWOT Analysis 12.3.6 Acros Organics Recent Developments 12.4 AlliChem 12.4.1 AlliChem Corporation Information 12.4.2 AlliChem Overview 12.4.3 AlliChem Valeramide Sales, Revenue, Price and Gross Margin (2017-2022) 12.4.4 AlliChem Valeramide Products and Services 12.4.5 AlliChem Valeramide SWOT Analysis 12.4.6 AlliChem Recent Developments 12.5 Waterstone Technology 12.5.1 Waterstone Technology Corporation Information 12.5.2 Waterstone Technology Overview 12.5.3 Waterstone Technology Valeramide Sales, Revenue, Price and Gross Margin (2017-2022) 12.5.4 Waterstone Technology Valeramide Products and Services 12.5.5 Waterstone Technology Valeramide SWOT Analysis 12.5.6 Waterstone Technology Recent Developments 12.6 City Chemical 12.6.1 City Chemical Corporation Information 12.6.2 City Chemical Overview 12.6.3 City Chemical Valeramide Sales, Revenue, Price and Gross Margin (2017-2022) 12.6.4 City Chemical Valeramide Products and Services 12.6.5 City Chemical Valeramide SWOT Analysis 12.6.6 City Chemical Recent Developments 12.7 3B Scientific 12.7.1 3B Scientific Corporation Information 12.7.2 3B Scientific Overview 12.7.3 3B Scientific Valeramide Sales, Revenue, Price and Gross Margin (2017-2022) 12.7.4 3B Scientific Valeramide Products and Services 12.7.5 3B Scientific Valeramide SWOT Analysis 12.7.6 3B Scientific Recent Developments 12.8 VWR International 12.8.1 VWR International Corporation Information 12.8.2 VWR International Overview 12.8.3 VWR International Valeramide Sales, Revenue, Price and Gross Margin (2017-2022) 12.8.4 VWR International Valeramide Products and Services 12.8.5 VWR International Valeramide SWOT Analysis 12.8.6 VWR International Recent Developments 12.9 Pfaltz & Bauer 12.9.1 Pfaltz & Bauer Corporation Information 12.9.2 Pfaltz & Bauer Overview 12.9.3 Pfaltz & Bauer Valeramide Sales, Revenue, Price and Gross Margin (2017-2022) 12.9.4 Pfaltz & Bauer Valeramide Products and Services 12.9.5 Pfaltz & Bauer Valeramide SWOT Analysis 12.9.6 Pfaltz & Bauer Recent Developments 12.10 Kanto Chemical 12.10.1 Kanto Chemical Corporation Information 12.10.2 Kanto Chemical Overview 12.10.3 Kanto Chemical Valeramide Sales, Revenue, Price and Gross Margin (2017-2022) 12.10.4 Kanto Chemical Valeramide Products and Services 12.10.5 Kanto Chemical Valeramide SWOT Analysis 12.10.6 Kanto Chemical Recent Developments 12.11 J & K SCIENTIFIC 12.11.1 J & K SCIENTIFIC Corporation Information 12.11.2 J & K SCIENTIFIC Overview 12.11.3 J & K SCIENTIFIC Valeramide Sales, Revenue, Price and Gross Margin (2017-2022) 12.11.4 J & K SCIENTIFIC Valeramide Products and Services 12.11.5 J & K SCIENTIFIC Recent Developments 12.12 Meryer (Shanghai) Chemical Technology 12.12.1 Meryer (Shanghai) Chemical Technology Corporation Information 12.12.2 Meryer (Shanghai) Chemical Technology Overview 12.12.3 Meryer (Shanghai) Chemical Technology Valeramide Sales, Revenue, Price and Gross Margin (2017-2022) 12.12.4 Meryer (Shanghai) Chemical Technology Valeramide Products and Services 12.12.5 Meryer (Shanghai) Chemical Technology Recent Developments 12.13 Energy Chemical 12.13.1 Energy Chemical Corporation Information 12.13.2 Energy Chemical Overview 12.13.3 Energy Chemical Valeramide Sales, Revenue, Price and Gross Margin (2017-2022) 12.13.4 Energy Chemical Valeramide Products and Services 12.13.5 Energy Chemical Recent Developments 12.14 Adamas Reagent 12.14.1 Adamas Reagent Corporation Information 12.14.2 Adamas Reagent Overview 12.14.3 Adamas Reagent Valeramide Sales, Revenue, Price and Gross Margin (2017-2022) 12.14.4 Adamas Reagent Valeramide Products and Services 12.14.5 Adamas Reagent Recent Developments 13 Value Chain and Sales Channels Analysis 13.1 Valeramide Value Chain Analysis 13.2 Valeramide Key Raw Materials 13.2.1 Key Raw Materials 13.2.2 Raw Materials Key Suppliers 13.3 Valeramide Production Mode & Process 13.4 Valeramide Sales and Marketing 13.4.1 Valeramide Sales Channels 13.4.2 Valeramide Distributors 13.5 Valeramide Customers 14 Key Findings 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer

List of Tables Table 1. Global Valeramide Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million) Table 2. Major Manufacturers of Purity 97% Table 3. Major Manufacturers of Purity 98% Table 4. Major Manufacturers of Purity 99% Table 5. Global Valeramide Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million) Table 6. Global Valeramide Production by Region: 2017 VS 2021 VS 2028 (K MT) Table 7. Global Valeramide Production by Region (2017-2022) & (K MT) Table 8. Global Valeramide Production Market Share by Region (2017-2022) Table 9. Global Valeramide Production by Region (2023-2028) & (K MT) Table 10. Global Valeramide Production Market Share by Region (2023-2028) Table 11. Valeramide Market Trends Table 12. Valeramide Market Drivers Table 13. Valeramide Market Challenges Table 14. Valeramide Market Restraints Table 15. Global Valeramide Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million) Table 16. Global Valeramide Sales by Region (2017-2022) & (K MT) Table 17. Global Valeramide Sales Market Share by Region (2017-2022) Table 18. Global Valeramide Sales by Region (2023-2028) & (K MT) Table 19. Global Valeramide Sales Market Share by Region (2023-2028) Table 20. Global Valeramide Revenue by Region (2017-2022) & (US$ Million) Table 21. Global Valeramide Revenue Market Share by Region (2017-2022) Table 22. Global Valeramide Revenue by Region (2023-2028) & (US$ Million) Table 23. Global Valeramide Revenue Market Share by Region (2023-2028) Table 24. Global Valeramide Production Capacity by Manufacturers (2017-2022) & (K MT) Table 25. Global Valeramide Capacity Market Share by Manufacturers (2017-2022) Table 26. Global Valeramide Production by Manufacturers (2017-2022) & (K MT) Table 27. Global Valeramide Production Market Share by Manufacturers (2017-2022) Table 28. Global Valeramide Sales by Manufacturers (2017-2022) & (K MT) Table 29. Global Valeramide Sales Share by Manufacturers (2017-2022) Table 30. Global Valeramide Revenue by Manufacturers (2017-2022) & (US$ Million) Table 31. Global Valeramide Revenue Share by Manufacturers (2017-2022) Table 32. Valeramide Price by Manufacturers 2017-2022 (USD/MT) Table 33. Global Valeramide Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Valeramide by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Valeramide as of 2021) Table 35. Valeramide Manufacturing Base Distribution and Headquarters Table 36. Manufacturers Valeramide Product Offered Table 37. Date of Key Manufacturers Enter into Valeramide Market Table 38. Mergers & Acquisitions, Expansion Plans Table 39. Global Valeramide Sales by Type (2017-2022) & (K MT) Table 40. Global Valeramide Sales by Type (2023-2028) & (K MT) Table 41. Global Valeramide Sales Share by Type (2017-2022) Table 42. Global Valeramide Sales Share by Type (2023-2028) Table 43. Global Valeramide Revenue by Type (2017-2022) & (US$ Million) Table 44. Global Valeramide Revenue by Type (2023-2028) & (US$ Million) Table 45. Global Valeramide Revenue Share by Type (2017-2022) Table 46. Global Valeramide Revenue Share by Type (2023-2028) Table 47. Valeramide Price by Type (2017-2022) & (USD/MT) Table 48. Global Valeramide Price Forecast by Type (2023-2028) & (USD/MT) Table 49. Global Valeramide Sales by Application (2017-2022) & (K MT) Table 50. Global Valeramide Sales by Application (2023-2028) & (K MT) Table 51. Global Valeramide Sales Share by Application (2017-2022) Table 52. Global Valeramide Sales Share by Application (2023-2028) Table 53. Global Valeramide Revenue by Application (2017-2022) & (US$ Million) Table 54. Global Valeramide Revenue by Application (2023-2028) & (US$ Million) Table 55. Global Valeramide Revenue Share by Application (2017-2022) Table 56. Global Valeramide Revenue Share by Application (2023-2028) Table 57. Valeramide Price by Application (2017-2022) & (USD/MT) Table 58. Global Valeramide Price Forecast by Application (2023-2028) & (USD/MT) Table 59. North America Valeramide Sales by Company (2017-2022) & (K MT) Table 60. North America Valeramide Sales Market Share by Company (2017-2022) Table 61. North America Valeramide Revenue by Company (2017-2022) & (US$ Million) Table 62. North America Valeramide Revenue Market Share by Company (2017-2022) Table 63. North America Valeramide Sales by Type (2017-2022) & (K MT) Table 64. North America Valeramide Sales by Type (2023-2028) & (K MT) Table 65. North America Valeramide Revenue by Type (2017-2022) & (US$ Million) Table 66. North America Valeramide Revenue by Type (2023-2028) & (US$ Million) Table 67. North America Valeramide Sales by Application (2017-2022) & (K MT) Table 68. North America Valeramide Sales by Application (2023-2028) & (K MT) Table 69. North America Valeramide Revenue by Application (2017-2022) & (US$ Million) Table 70. North America Valeramide Revenue by Application (2023-2028) & (US$ Million) Table 71. North America Valeramide Sales by Country (2017-2022) & (K MT) Table 72. North America Valeramide Sales by Country (2023-2028) & (K MT) Table 73. North America Valeramide Revenue by Country (2017-2022) & (US$ Million) Table 74. North America Valeramide Revenue by Country (2023-2028) & (US$ Million) Table 75. Europe Valeramide Sales by Company (2017-2022) & (K MT) Table 76. Europe Valeramide Sales Market Share by Company (2017-2022) Table 77. Europe Valeramide Revenue by Company (2017-2022) & (US$ Million) Table 78. Europe Valeramide Revenue Market Share by Company (2017-2022) Table 79. Europe Valeramide Sales by Type (2017-2022) & (K MT) Table 80. Europe Valeramide Sales by Type (2023-2028) & (K MT) Table 81. Europe Valeramide Revenue by Type (2017-2022) & (US$ Million) Table 82. Europe Valeramide Revenue by Type (2023-2028) & (US$ Million) Table 83. Europe Valeramide Sales by Application (2017-2022) & (K MT) Table 84. Europe Valeramide Sales by Application (2023-2028) & (K MT) Table 85. Europe Valeramide Revenue by Application (2017-2022) & (US$ Million) Table 86. Europe Valeramide Revenue by Application (2023-2028) & (US$ Million) Table 87. Europe Valeramide Sales by Country (2017-2022) & (K MT) Table 88. Europe Valeramide Sales by Country (2023-2028) & (K MT) Table 89. Europe Valeramide Revenue by Country (2017-2022) & (US$ Million) Table 90. Europe Valeramide Revenue by Country (2023-2028) & (US$ Million) Table 91. Asia Pacific Valeramide Sales by Company (2017-2022) & (K MT) Table 92. Asia Pacific Valeramide Sales Market Share by Company (2017-2022) Table 93. Asia Pacific Valeramide Revenue by Company (2017-2022) & (US$ Million) Table 94. Asia Pacific Valeramide Revenue Market Share by Company (2017-2022) Table 95. Asia Pacific Valeramide Sales by Type (2017-2022) & (K MT) Table 96. Asia Pacific Valeramide Sales by Type (2023-2028) & (K MT) Table 97. Asia Pacific Valeramide Revenue by Type (2017-2022) & (US$ Million) Table 98. Asia Pacific Valeramide Revenue by Type (2023-2028) & (US$ Million) Table 99. Asia Pacific Valeramide Sales by Application (2017-2022) & (K MT) Table 100. Asia Pacific Valeramide Sales by Application (2023-2028) & (K MT) Table 101. Asia Pacific Valeramide Revenue by Application (2017-2022) & (US$ Million) Table 102. Asia Pacific Valeramide Revenue by Application (2023-2028) & (US$ Million) Table 103. Asia Pacific Valeramide Sales by Region (2017-2022) & (K MT) Table 104. Asia Pacific Valeramide Sales by Region (2023-2028) & (K MT) Table 105. Asia Pacific Valeramide Revenue by Region (2017-2022) & (US$ Million) Table 106. Asia Pacific Valeramide Revenue by Region (2023-2028) & (US$ Million) Table 107. Latin America Valeramide Sales by Company (2017-2022) & (K MT) Table 108. Latin America Valeramide Sales Market Share by Company (2017-2022) Table 109. Latin America Valeramide Revenue by Company (2017-2022) & (US$ Million) Table 110. Latin America Valeramide Revenue Market Share by Company (2017-2022) Table 111. Latin America Valeramide Sales by Type (2017-2022) & (K MT) Table 112. Latin America Valeramide Sales by Type (2023-2028) & (K MT) Table 113. Latin America Valeramide Revenue by Type (2017-2022) & (US$ Million) Table 114. Latin America Valeramide Revenue by Type (2023-2028) & (US$ Million) Table 115. Latin America Valeramide Sales by Application (2017-2022) & (K MT) Table 116. Latin America Valeramide Sales by Application (2023-2028) & (K MT) Table 117. Latin America Valeramide Revenue by Application (2017-2022) & (US$ Million) Table 118. Latin America Valeramide Revenue by Application (2023-2028) & (US$ Million) Table 119. Latin America Valeramide Sales by Country (2017-2022) & (K MT) Table 120. Latin America Valeramide Sales by Country (2023-2028) & (K MT) Table 121. Latin America Valeramide Revenue by Country (2017-2022) & (US$ Million) Table 122. Latin America Valeramide Revenue by Country (2023-2028) & (US$ Million) Table 123. Middle East and Africa Valeramide Sales by Company (2017-2022) & (K MT) Table 124. Middle East and Africa Valeramide Sales Market Share by Company (2017-2022) Table 125. Middle East and Africa Valeramide Revenue by Company (2017-2022) & (US$ Million) Table 126. Middle East and Africa Valeramide Revenue Market Share by Company (2017-2022) Table 127. Middle East and Africa Valeramide Sales by Type (2017-2022) & (K MT) Table 128. Middle East and Africa Valeramide Sales by Type (2023-2028) & (K MT) Table 129. Middle East and Africa Valeramide Revenue by Type (2017-2022) & (US$ Million) Table 130. Middle East and Africa Valeramide Revenue by Type (2023-2028) & (US$ Million) Table 131. Middle East and Africa Valeramide Sales by Application (2017-2022) & (K MT) Table 132. Middle East and Africa Valeramide Sales by Application (2023-2028) & (K MT) Table 133. Middle East and Africa Valeramide Revenue by Application (2017-2022) & (US$ Million) Table 134. Middle East and Africa Valeramide Revenue by Application (2023-2028) & (US$ Million) Table 135. Middle East and Africa Valeramide Sales by Country (2017-2022) & (K MT) Table 136. Middle East and Africa Valeramide Sales by Country (2023-2028) & (K MT) Table 137. Middle East and Africa Valeramide Revenue by Country (2017-2022) & (US$ Million) Table 138. Middle East and Africa Valeramide Revenue by Country (2023-2028) & (US$ Million) Table 139. TCI Corporation Information Table 140. TCI Description and Overview Table 141. TCI Valeramide Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2017-2022) Table 142. TCI Valeramide Products and Services Table 143. TCI Valeramide SWOT Analysis Table 144. TCI Recent Development Table 145. Alfa Chemistry Corporation Information Table 146. Alfa Chemistry Description and Overview Table 147. Alfa Chemistry Valeramide Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2017-2022) Table 148. Alfa Chemistry Valeramide Products and Services Table 149. Alfa Chemistry Valeramide SWOT Analysis Table 150. Alfa Chemistry Recent Development Table 151. Acros Organics Corporation Information Table 152. Acros Organics Description and Overview Table 153. Acros Organics Valeramide Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2017-2022) Table 154. Acros Organics Valeramide Products and Services Table 155. Acros Organics Valeramide SWOT Analysis Table 156. Acros Organics Recent Development Table 157. AlliChem Corporation Information Table 158. AlliChem Description and Overview Table 159. AlliChem Valeramide Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2017-2022) Table 160. AlliChem Valeramide Products and Services Table 161. AlliChem Valeramide SWOT Analysis Table 162. AlliChem Recent Development Table 163. Waterstone Technology Corporation Information Table 164. Waterstone Technology Description and Overview Table 165. Waterstone Technology Valeramide Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2017-2022) Table 166. Waterstone Technology Valeramide Products and Services Table 167. Waterstone Technology Valeramide SWOT Analysis Table 168. Waterstone Technology Recent Development Table 169. City Chemical Corporation Information Table 170. City Chemical Description and Overview Table 171. City Chemical Valeramide Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2017-2022) Table 172. City Chemical Valeramide Products and Services Table 173. City Chemical Valeramide SWOT Analysis Table 174. City Chemical Recent Development Table 175. 3B Scientific Corporation Information Table 176. 3B Scientific Description and Overview Table 177. 3B Scientific Valeramide Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2017-2022) Table 178. 3B Scientific Valeramide Products and Services Table 179. 3B Scientific Valeramide SWOT Analysis Table 180. 3B Scientific Recent Development Table 181. VWR International Corporation Information Table 182. VWR International Description and Overview Table 183. VWR International Valeramide Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2017-2022) Table 184. VWR International Valeramide Products and Services Table 185. VWR International Valeramide SWOT Analysis Table 186. VWR International Recent Development Table 187. Pfaltz & Bauer Corporation Information Table 188. Pfaltz & Bauer Description and Overview Table 189. Pfaltz & Bauer Valeramide Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2017-2022) Table 190. Pfaltz & Bauer Valeramide Products and Services Table 191. Pfaltz & Bauer Valeramide SWOT Analysis Table 192. Pfaltz & Bauer Recent Development Table 193. Kanto Chemical Corporation Information Table 194. Kanto Chemical Description and Overview Table 195. Kanto Chemical Valeramide Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2017-2022) Table 196. Kanto Chemical Valeramide Products and Services Table 197. Kanto Chemical Valeramide SWOT Analysis Table 198. Kanto Chemical Recent Development Table 199. J & K SCIENTIFIC Corporation Information Table 200. J & K SCIENTIFIC Description and Overview Table 201. J & K SCIENTIFIC Valeramide Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2017-2022) Table 202. J & K SCIENTIFIC Valeramide Products and Services Table 203. J & K SCIENTIFIC Recent Development Table 204. Meryer (Shanghai) Chemical Technology Corporation Information Table 205. Meryer (Shanghai) Chemical Technology Description and Overview Table 206. Meryer (Shanghai) Chemical Technology Valeramide Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2017-2022) Table 207. Meryer (Shanghai) Chemical Technology Valeramide Products and Services Table 208. Meryer (Shanghai) Chemical Technology Recent Development Table 209. Energy Chemical Corporation Information Table 210. Energy Chemical Description and Overview Table 211. Energy Chemical Valeramide Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2017-2022) Table 212. Energy Chemical Valeramide Products and Services Table 213. Energy Chemical Recent Development Table 214. Adamas Reagent Corporation Information Table 215. Adamas Reagent Description and Overview Table 216. Adamas Reagent Valeramide Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2017-2022) Table 217. Adamas Reagent Valeramide Products and Services Table 218. Adamas Reagent Recent Development Table 219. Key Raw Materials Lists Table 220. Raw Materials Key Suppliers Lists Table 221. Valeramide Distributors List Table 222. Valeramide Customers List Table 223. Research Programs/Design for This Report Table 224. Key Data Information from Secondary Sources Table 225. Key Data Information from Primary Sources List of Figures Figure 1. Valeramide Product Picture Figure 2. Global Valeramide Market Share by Type in 2021 & 2028 Figure 3. Purity 97% Product Picture Figure 4. Purity 98% Product Picture Figure 5. Purity 99% Product Picture Figure 6. Global Valeramide Market Share by Application in 2021 & 2028 Figure 7. Chemical Reagents Figure 8. Pharmaceutical Intermediates Figure 9. Others Figure 10. Valeramide Report Years Considered Figure 11. Global Valeramide Capacity, Production and Utilization (2017-2028) & (K MT) Figure 12. Global Valeramide Production Market Share by Region in Percentage: 2021 Versus 2028 Figure 13. Global Valeramide Production Market Share by Region (2017-2022) Figure 14. Global Valeramide Production Market Share by Region (2023-2028) Figure 15. Valeramide Production Growth Rate in North America (2017-2028) & (K MT) Figure 16. Valeramide Production Growth Rate in Europe (2017-2028) & (K MT) Figure 17. Valeramide Production Growth Rate in Japan (2017-2028) & (K MT) Figure 18. Valeramide Production Growth Rate in China (2017-2028) & (K MT) Figure 19. Valeramide Production Growth Rate in South Korea (2017-2028) & (K MT) Figure 20. Valeramide Production Growth Rate in India (2017-2028) & (K MT) Figure 21. Global Valeramide Sales 2017-2028 (K MT) Figure 22. Global Valeramide Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 23. Global Valeramide Revenue 2017-2028 (US$ Million) Figure 24. Global Valeramide Revenue Market Share by Region in Percentage: 2021 Versus 2028 Figure 25. Global Valeramide Sales Market Share by Region (2017-2022) Figure 26. Global Valeramide Sales Market Share by Region (2023-2028) Figure 27. North America Valeramide Sales YoY (2017-2028) & (K MT) Figure 28. North America Valeramide Revenue YoY (2017-2028) & (US$ Million) Figure 29. Europe Valeramide Sales YoY (2017-2028) & (K MT) Figure 30. Europe Valeramide Revenue YoY (2017-2028) & (US$ Million) Figure 31. Asia-Pacific Valeramide Sales YoY (2017-2028) & (K MT) Figure 32. Asia-Pacific Valeramide Revenue YoY (2017-2028) & (US$ Million) Figure 33. Latin America Valeramide Sales YoY (2017-2028) & (K MT) Figure 34. Latin America Valeramide Revenue YoY (2017-2028) & (US$ Million) Figure 35. Middle East & Africa Valeramide Sales YoY (2017-2028) & (K MT) Figure 36. Middle East & Africa Valeramide Revenue YoY (2017-2028) & (US$ Million) Figure 37. The Top 10 and Top 5 Players Market Share by Valeramide Sales in 2021 Figure 38. The Top 10 and Top 5 Players Market Share by Valeramide Revenue in 2021 Figure 39. Valeramide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021 Figure 40. Global Valeramide Sales Market Share by Type (2017-2028) Figure 41. Global Valeramide Revenue Market Share by Type (2017-2028) Figure 42. Global Valeramide Sales Market Share by Application (2017-2028) Figure 43. Global Valeramide Revenue Market Share by Application (2017-2028) Figure 44. North America Valeramide Sales Market Share by Type (2017-2028) Figure 45. North America Valeramide Revenue Market Share by Type (2017-2028) Figure 46. North America Valeramide Sales Market Share by Application (2017-2028) Figure 47. North America Valeramide Revenue Market Share by Application (2017-2028) Figure 48. North America Valeramide Sales Share by Country (2017-2028) Figure 49. North America Valeramide Revenue Share by Country (2017-2028) Figure 50. U.S. Valeramide Revenue (2017-2028) & (US$ Million) Figure 51. Canada Valeramide Revenue (2017-2028) & (US$ Million) Figure 52. Europe Valeramide Sales Market Share by Type (2017-2028) Figure 53. Europe Valeramide Revenue Market Share by Type (2017-2028) Figure 54. Europe Valeramide Sales Market Share by Application (2017-2028) Figure 55. Europe Valeramide Revenue Market Share by Application (2017-2028) Figure 56. Europe Valeramide Sales Share by Country (2017-2028) Figure 57. Europe Valeramide Revenue Share by Country (2017-2028) Figure 58. Germany Valeramide Revenue (2017-2028) & (US$ Million) Figure 59. France Valeramide Revenue (2017-2028) & (US$ Million) Figure 60. U.K. Valeramide Revenue (2017-2028) & (US$ Million) Figure 61. Italy Valeramide Revenue (2017-2028) & (US$ Million) Figure 62. Russia Valeramide Revenue (2017-2028) & (US$ Million) Figure 63. Asia-Pacific Valeramide Sales Market Share by Type (2017-2028) Figure 64. Asia-Pacific Valeramide Revenue Market Share by Type (2017-2028) Figure 65. Asia-Pacific Valeramide Sales Market Share by Application (2017-2028) Figure 66. Asia-Pacific Valeramide Revenue Market Share by Application (2017-2028) Figure 67. Asia-Pacific Valeramide Sales Share by Region (2017-2028) Figure 68. Asia-Pacific Valeramide Revenue Share by Region (2017-2028) Figure 69. China Valeramide Revenue (2017-2028) & (US$ Million) Figure 70. Japan Valeramide Revenue (2017-2028) & (US$ Million) Figure 71. South Korea Valeramide Revenue (2017-2028) & (US$ Million) Figure 72. India Valeramide Revenue (2017-2028) & (US$ Million) Figure 73. Australia Valeramide Revenue (2017-2028) & (US$ Million) Figure 74. Taiwan Valeramide Revenue (2017-2028) & (US$ Million) Figure 75. Indonesia Valeramide Revenue (2017-2028) & (US$ Million) Figure 76. Thailand Valeramide Revenue (2017-2028) & (US$ Million) Figure 77. Malaysia Valeramide Revenue (2017-2028) & (US$ Million) Figure 78. Philippines Valeramide Revenue (2017-2028) & (US$ Million) Figure 79. Latin America Valeramide Sales Market Share by Type (2017-2028) Figure 80. Latin America Valeramide Revenue Market Share by Type (2017-2028) Figure 81. Latin America Valeramide Sales Market Share by Application (2017-2028) Figure 82. Latin America Valeramide Revenue Market Share by Application (2017-2028) Figure 83. Latin America Valeramide Sales Share by Country (2017-2028) Figure 84. Latin America Valeramide Revenue Share by Country (2017-2028) Figure 85. Mexico Valeramide Revenue (2017-2028) & (US$ Million) Figure 86. Brazil Valeramide Revenue (2017-2028) & (US$ Million) Figure 87. Argentina Valeramide Revenue (2017-2028) & (US$ Million) Figure 88. Middle East & Africa Valeramide Sales Market Share by Type (2017-2028) Figure 89. Middle East & Africa Valeramide Revenue Market Share by Type (2017-2028) Figure 90. Middle East & Africa Valeramide Sales Market Share by Application (2017-2028) Figure 91. Middle East & Africa Valeramide Revenue Market Share by Application (2017-2028) Figure 92. Middle East & Africa Valeramide Sales Share by Country (2017-2028) Figure 93. Middle East & Africa Valeramide Revenue Share by Country (2017-2028) Figure 94. Turkey Valeramide Revenue (2017-2028) & (US$ Million) Figure 95. Saudi Arabia Valeramide Revenue (2017-2028) & (US$ Million) Figure 96. U.A.E Valeramide Revenue (2017-2028) & (US$ Million) Figure 97. Valeramide Value Chain Figure 98. Valeramide Production Process Figure 99. Channels of Distribution Figure 100. Distributors Profiles Figure 101. Bottom-up and Top-down Approaches for This Report Figure 102. Data Triangulation Figure 103. Key Executives Interviewed

TCI Alfa Chemistry Acros Organics AlliChem Waterstone Technology City Chemical 3B Scientific VWR International Pfaltz & Bauer Kanto Chemical J & K SCIENTIFIC Meryer (Shanghai) Chemical Technology Energy Chemical Adamas Reagent